Trials / Completed
CompletedNCT01531855
Post-exercise Insulin Reductions in Type 1 Diabetes
The Metabolic and Glycaemic Responses to Reductions in Rapid-acting Insulin Dose After Running Exercise in People With Type 1 Diabetes Mellitus.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 13 (actual)
- Sponsor
- Northumbria University · Academic / Other
- Sex
- Male
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
The investigators hypothesise that reducing rapid-acting insulin dose after exercise will help prevent Type 1 diabetes individuals experiencing hypoglycaemia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Reducing post-exercise rapid-acting insulin (insulin lispro or aspart) dose | Dosage after exercise |
Timeline
- Start date
- 2012-02-01
- Primary completion
- 2012-08-01
- Completion
- 2012-08-01
- First posted
- 2012-02-13
- Last updated
- 2014-08-04
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT01531855. Inclusion in this directory is not an endorsement.